Watch the full video on YoutTube. EASD TV host, Vivienne Parry is joined by Bastian Hauck and Renza Scibilia from the Diabetes Online Community (DOC) to discuss some of the most pressing topics facing people living with type 1 diabetes.

The conversation explores the growing interest in emerging therapies - including the off-label use of GLP-1 receptor agonists in type 1 diabetes - the rapid evolution of continuous glucose monitoring technologies, responsible stewardship of health data, and the ongoing global effort to end diabetes stigma.

Central to the discussion is the importance of ensuring that people with lived experience are involved in shaping research, innovation and healthcare policy. As Bastian reminds us throughout the episode, meaningful progress begins with one simple principle: "Nothing about us without us."

This episode is dedicated to the memory of our friend and colleague, Bastian Hauck, whose passion for patient advocacy and unwavering commitment to ensuring that people living with diabetes always had a voice continue to inspire the global diabetes community.

Explore our speaker's profile:

For more episodes, visit our podcast archive.

Watch the full video on YouTube. Does exercising in the morning, afternoon or evening make a difference for metabolic health?

In this episode, Dr Jeroen van der Velde discusses the latest evidence on exercise timing and type 2 diabetes, exploring how circadian rhythms influence glucose metabolism and why later-day exercise may offer additional benefits for glycaemic control.

Topics discussed include:

Learn more about the speaker:

For more content from previous episodes, visit our podcast archive.

Watch the full video on YouTube.

In this episode, Elizabeth Robertson (Diabetes UK) and Rachel Connor (Breakthrough T1D) discuss one of the most exciting developments in diabetes research: the growing possibility of delaying and ultimately preventing type 1 diabetes.

Topics discussed include:

For more content from previous episodes, visit our podcast archive.

Watch the full video on YouTube. In this episode, Vivienne Parry speaks with former EASD President Prof. Stefano Del Prato about leading the Association through the COVID-19 pandemic and how one of the most challenging periods in EASD's history became a catalyst for lasting change.

Discover how the rapid transition to a virtual Annual Meeting expanded EASD's global reach, inspired the creation of the Global Council and strengthened international collaboration across the diabetes community.

Prof. Del Prato also reflects on the importance of in-person scientific meetings, the continued evolution of the EASD Annual Meeting and the innovations that are shaping its future.

Explore our speaker's profile:

For more episodes, visit our podcast archive.

Watch the full video on YouTube. In this episode, Vivienne Parry is joined by Prof. João Filipe Raposo (Portugal) and Prof. Harald Sourij (Austria) for a lively discussion on the opportunities and challenges of artificial intelligence in diabetes care.

Discover how AI is already supporting diabetes management through automated insulin delivery systems, continuous glucose monitoring and personalised risk prediction, while also exploring the evidence still needed before wider implementation in routine clinical practice.

The discussion also covers data privacy, regulation, patient trust and why human expertise and shared decision-making remain essential as AI becomes increasingly integrated into healthcare.

Explore our speakers' profiles:

For more episodes, visit our podcast archive.

Watch the full video on YouTube. In this episode of Diabetes Insights, Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about why EASD has become one of the world's leading forums for diabetes research and collaboration.

The discussion explores how differences in diabetes phenotypes between Europe and East Asia are helping researchers better understand the disease, improve treatments and develop new scientific collaborations across continents.

Professor Yabe also discusses the exciting progress being made in regenerative medicine, including clinical trials using iPS cell-derived islet cells for people living with type 1 diabetes. He explains how this approach could help overcome donor shortages and bring scalable cell therapies closer to clinical practice.

Topics covered:

Featured speaker:

For more content from previous episodes, visit our podcast archive.

Watch the full video on YouTube. In this episode of Diabetes Insights, Prof. Thomas Karagiannis and Dr Francesco Zaccardi explain the rigorous methodology behind the first EASD clinical guidelines and why robust evidence-based processes are essential for producing trustworthy recommendations.

Discover how guideline development panels are assembled, how conflicts of interest are managed, and why patient perspectives are incorporated alongside scientific evidence. The discussion also explores the first EASD guideline on diabetes distress, future guidance on continuous glucose monitoring in type 2 diabetes, and prevention strategies for people at risk of developing type 2 diabetes..

Featured speaker:

For more content from previous episodes, visit our podcast archive.

Watch the full video on YouTube. Continuous glucose monitoring (CGM) is becoming an increasingly important part of diabetes care, but how should it be used in people living with type 2 diabetes?

In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on CGM in type 2 diabetes. They explain how guideline topics are selected, the rigorous process of reviewing evidence, and why patient perspectives are essential to developing meaningful recommendations.

The discussion explores outcomes beyond HbA1c, including quality of life, confidence in self-management, behaviour change, and broader health impacts. The speakers also consider how future recommendations could influence clinical practice, healthcare policy, and access to diabetes technology.

Explore the latest EASD Annual Meeting presentations and learn more about our featured speakers:

For more content from our previous episodes, visit our podcast archive.

Watch the the full video on YouTube. In this special episode, Prof. Eberhard Standl celebrates an extraordinary milestone: 50 years since attending his first EASD Congress in 1975.

Prof. Standl reflects on the remarkable progress made in diabetes research and clinical care over the past five decades, from managing diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, and emerging therapies for both type 1 and type 2 diabetes.

The discussion explores the enduring importance of lifestyle interventions, patient-clinician partnerships, diabetes remission, and exciting new research linking diabetes, obesity, metabolism, and cancer.

Explore the latest EASD Annual Meeting presentations and learn more about our featured speaker:

For more content from previous episodes, visit our podcast archive.

Watch the full video on YouTube. In this episode, Prof. Richard Holt and Prof. Kirsten Nørgaard discuss the updated EASD-ADA Consensus Report on Type 1 Diabetes and explain the key developments shaping modern type 1 diabetes care.

Topics discussed include:

Featured speakers:

For more content from previous episodes, visit our podcast archive.